company background image
FLGT

Fulgent Genetics NasdaqGM:FLGT Stock Report

Last Price

US$34.76

Market Cap

US$1.1b

7D

6.5%

1Y

-44.5%

Updated

29 Jan, 2023

Data

Company Financials +

FLGT Stock Overview

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.

FLGT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

My Notes

New

Notes are coming soon

Fulgent Genetics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fulgent Genetics
Historical stock prices
Current Share PriceUS$34.76
52 Week HighUS$73.47
52 Week LowUS$28.53
Beta1.58
1 Month Change16.72%
3 Month Change-12.29%
1 Year Change-44.51%
3 Year Change159.79%
5 Year Change674.16%
Change since IPO278.65%

Recent News & Updates

Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)

Jan 15
Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)

Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?

Dec 28
Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?

Recent updates

Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)

Jan 15
Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)

Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?

Dec 28
Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?

What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates

Nov 16
What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates

Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching

Oct 27
Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching

We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending

Sep 19
We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending

Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly

Sep 05
Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly

Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement

Jul 21
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement

Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency

Jun 04
Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency

These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely

May 04
These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely

Fulgent Genetics (NASDAQ:FLGT) Has A Rock Solid Balance Sheet

Jan 25
Fulgent Genetics (NASDAQ:FLGT) Has A Rock Solid Balance Sheet

I Ran A Stock Scan For Earnings Growth And Fulgent Genetics (NASDAQ:FLGT) Passed With Ease

Dec 14
I Ran A Stock Scan For Earnings Growth And Fulgent Genetics (NASDAQ:FLGT) Passed With Ease

These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely

At US$85.24, Is Fulgent Genetics, Inc. (NASDAQ:FLGT) Worth Looking At Closely?

Sep 25
At US$85.24, Is Fulgent Genetics, Inc. (NASDAQ:FLGT) Worth Looking At Closely?

If You Like EPS Growth Then Check Out Fulgent Genetics (NASDAQ:FLGT) Before It's Too Late

Sep 07
If You Like EPS Growth Then Check Out Fulgent Genetics (NASDAQ:FLGT) Before It's Too Late

Is Fulgent Genetics (NASDAQ:FLGT) A Risky Investment?

Jul 16
Is Fulgent Genetics (NASDAQ:FLGT) A Risky Investment?

Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching

Jun 04
Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching

We Take A Look At Whether Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO May Be Underpaid

May 14
We Take A Look At Whether Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO May Be Underpaid

Shareholder Returns

FLGTUS HealthcareUS Market
7D6.5%0.2%2.8%
1Y-44.5%-0.2%-9.2%

Return vs Industry: FLGT underperformed the US Healthcare industry which returned -0.2% over the past year.

Return vs Market: FLGT underperformed the US Market which returned -9.2% over the past year.

Price Volatility

Is FLGT's price volatile compared to industry and market?
FLGT volatility
FLGT Average Weekly Movement7.1%
Healthcare Industry Average Movement7.6%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.8%

Stable Share Price: FLGT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: FLGT's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011645Ming Hsiehhttps://www.fulgentgenetics.com

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2.

Fulgent Genetics, Inc. Fundamentals Summary

How do Fulgent Genetics's earnings and revenue compare to its market cap?
FLGT fundamental statistics
Market CapUS$1.05b
Earnings (TTM)US$271.57m
Revenue (TTM)US$802.94m

3.9x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
FLGT income statement (TTM)
RevenueUS$802.94m
Cost of RevenueUS$259.48m
Gross ProfitUS$543.45m
Other ExpensesUS$271.88m
EarningsUS$271.57m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)8.99
Gross Margin67.68%
Net Profit Margin33.82%
Debt/Equity Ratio1.6%

How did FLGT perform over the long term?

See historical performance and comparison